<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
V.I. Technologies, Inc.
-----------------------
(Name of Issuer)
Common Stock, $.01 par value
------------------------------
(Title of Class of Securities)
91720100
--------------
(CUSIP Number)
February 14, 1999
-------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
/ / Rule 13d-1 (b)
/ / Rule 13d-1 (c)
/X/ Rule 13d-1 (d)
<PAGE> 2
- --------------------------------------------------------------------------------
CUSIP NO. 917920100 PAGE 2 OF 5 PAGES
- --------------------------------------------------------------------------------
13G
- --------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
New York Blood Center, Inc.
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) /X/
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
New York
- --------------------------------------------------------------------------------
5. SOLE VOTING POWER 3,434,704 shares
NUMBER OF
SHARES -----------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER none
OWNED BY EACH
REPORTING -----------------------------------------------------
PERSON WITH 7. SOLE DISPOSITIVE POWER 3,434,704 shares
-----------------------------------------------------
8. SHARED DISPOSITIVE POWER none
- -------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,434,704 shares
- -------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* / /
- -------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
27.9%
- -------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
CO
- -------------------------------------------------------------------------------
<PAGE> 3
PAGE 3 OF 5 PAGES
ITEM 1(a). NAME OF ISSUER:
V.I. Technologies, Inc.
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
155 Duryea Road
Melville, New York 11747
ITEM 2(a). NAME OF PERSON FILING:
New York Blood Center, Inc.
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
310 E. 67th Street
New York, New York 10021
ITEM 2(c). CITIZENSHIP:
New York
ITEM 2(d). TITLE OF CLASS OF SECURITIES:
Common Stock, $.01 par value
ITEM 2(e). CUSIP NUMBER:
917920100
<PAGE> 4
PAGE 4 OF 5 PAGES
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR
13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS:
(a) / / A broker or dealer registered under Section 15 of the
Exchange Act.
(b) / / A bank as defined in Section 3(a)(6) of the Exchange
Act.
(c) / / An insurance company as defined in Section 3(a)(19) of
the Exchange Act.
(d) / / An investment company registered under Section 8 of
the Investment Company Act.
(e) / / An investment adviser in accordance with Rule
13d-1(b)(1)(ii)(E).
(f) / / An employee benefit plan or endowment fund in
accordance with Rule 13d-1(b)(1)(ii)(F).
(g) / / A parent holding company or control person, in
accordance with Rule 13d-1(b)(ii)(G).
(h) / / A savings association as defined in Section 3(b) of
the Federal Deposit Insurance Act.
(i) / / A church plan that is excluded from the definition of
an investment company under Section 3(c)(14) of the
Investment Company Act.
(j) / / A group, in accordance with Rule 13d-1(b)(ii)(J).
If this statement is filed pursuant to Rule 13d-1(c), check
this box. / /
ITEM 4. OWNERSHIP.
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
3,434,704 shares
(b) Percent of class:
27.9%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote 3,434,704 shares,
<PAGE> 5
PAGE 5 OF 5 PAGES
(ii) Shared power to vote or to direct the vote none,
(iii) Sole power to dispose or to direct the disposition of 3,434,704 shares,
(iv) Shared power to dispose or to direct the disposition of none,
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
Not applicable
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER
PERSON.
Not applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
COMPANY.
Not applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable
ITEM 10. CERTIFICATION.
Not applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
February 12, 1999
-------------------------------------
(Date)
/s/ John Wurmser
-------------------------------------
(Signature)
John Wurmser, Chief Financial Officer
-------------------------------------
(Name/Title)
